Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FD4WW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,670
Award facts
- Contract value 100% obligated
- $29,669.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, valued at $29,669.58, is scheduled for completion by August 29, 2025, and was awarded on August 8, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on a general basis leveraging its certified woman-owned small business status. Performance will be executed from the vendor's Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA's SPE2DB program, a $500 million blanket agreement through November 2026 that authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting military healthcare facilities worldwide. The contract encompasses branded and generic prescription drugs, biologics, and medical consumables across multiple product categories. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the DLA to distribute medications and medical supplies to Department of Defense healthcare installations globally.
Quick answers
Who was awarded contract SPE2DB25FD4WW?
SPE2DB25FD4WW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FD4WW worth?
The government has obligated $29,670 on SPE2DB25FD4WW.
Is contract SPE2DB25FD4WW an order under another contract?
Yes. SPE2DB25FD4WW is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4WW competed?
The extent of competition for SPE2DB25FD4WW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award